Neutrophil‐Derived Metalloproteinase‐9 Predicts Healing Quality after Sinus Surgery
- 2 January 2005
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 115 (1) , 56-61
- https://doi.org/10.1097/01.mlg.0000150674.30237.3f
Abstract
Background: In a recent study, we have shown that gelatinase-B (metalloproteinase [MMP]-9) in nasal secretions can have both monitoring and predictive value on the healing outcome after functional endoscopic sinus surgery (FESS) to treat chronic rhinosinusitis (CRS) and nasal polyposis (NP). In this work, we aimed to explore the source of MMP-9 and the influence of inflammation on MMP-9 expression and release in nasal tissue and secretions during airway remodelling after surgery. Methods: Biopsies from 23 patients operated by FESS for CRS or NP were collected 1, 3, and 6 months after sinus surgery. MMP-9 expression in the paranasal mucosa was correlated with healing quality, with MMP-9 concentrations in nasal fluid, and with histomorphologic findings (edema, fibrosis, αsmooth muscle actin, CD-68, myeloperoxidase, EG2, and transforming growth factor [TGF]-β1 stainings). Results: MMP-9 concentrations in nasal fluid were paralleled by MMP-9 expression inside the extracellular matrix (ECM) after sinus surgery. MMP-9 expression in ECM was significantly correlated with healing quality (r = 0.378, P = .0181), and poor healers presented significantly more edema (P < .05). The amounts of MMP-9 in nasal fluid were significantly and independently predicted by the number of neutrophils (P = .0224) and macrophages (P = .0497) in the tissue. In contrast, MMP-9 expression was not related to fibrosis, number of myofibroblasts, or TGF-β1 expression in ECM. Conclusions: MMP-9 expression is increased in the ECM during wound healing and parallels concentrations of MMP-9 in nasal fluids. Inflammatory cells represent the major source of increased MMP-9 expression, which is linked to poor healing quality.Keywords
This publication has 21 references indexed in Scilit:
- Predictive and monitoring value of matrix metalloproteinase‐9 for healing quality after sinus surgeryWound Repair and Regeneration, 2004
- Inducible Expression of Tissue Inhibitor of Metalloproteinases–Resistant Matrix Metalloproteinase-9 on the Cell Surface of NeutrophilsAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Increased Matrix Metalloproteinase-9 in the Airway after Allergen ChallengeAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Correlation between interleukin‐6 and matrix metalloproteinase‐9 in early wound healing in childrenWound Repair and Regeneration, 1999
- Contribution of 92 kDa Gelatinase/Type IV Collagenase in Bronchial Inflammation during Status AsthmaticusAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Human Neutrophils Secrete Gelatinase BIn VitroandIn Vivoin Response to Endotoxin and Proinflammatory MediatorsAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic BronchitisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophilsInflammation Research, 1998
- Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1997
- Matrix metalloproteinases and TIMP in acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1996